Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of observational studies-Reference-Cited by-同舟云学术

Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of observational studies

Published:2011-12 Issue:3 Volume:153 Page:249-255
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Kouz Remi,Kouz Simon,Schampaert Erick,Rinfret Stephane,Tardif Jean-Claude,Nguyen Michel,Eisenberg Mark,Harvey Richard,Afilalo Marc,Lauzon Claude,Dery Jean-Pierre,Mansour Samer,Huynh Thao

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction;Eisenberg;J Am Coll Cardiol,2003

2. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systemic overview of randomized clinical trials;Kandzari;Am Heart J,2004

3. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials;De Luca;JAMA,2005

4. Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: a meta-analysis of randomized, controlled trials;Araujo;Am Heart J,2004

5. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up;Montalescot;Eur Heart J,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of pre stenting intracoronary tirofiban followed by infusion in angiographically proven large thrombus burden : A randomized controlled study;Annales de Cardiologie et d'Angéiologie;2023-10

2. αIIbβ3 (GPIIb-IIIa) Antagonists;Platelets;2019

3. Apport de l’administration intracoronaire d’antithrombotiques par cathéter à ballon de perfusion en phase aiguë d’infarctus du myocarde avec thrombus massif et échec de la thromboaspiration;Annales de Cardiologie et d'Angéiologie;2016-11

4. The ‘MAP strategy’ (Maximum aspiration of atherothrombus and adjunctive glycoprotein IIb/IIIa inhibitor utilization combined with prolonged inflation of balloon/stent) for preventing no-reflow in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: A retrospective analysis of seventy-one cases;Indian Heart Journal;2015-12

5. The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI;The Anatolian Journal of Cardiology;2015-11-12